Evidence map›Paper›PMID 42860497›Full record

ArticleAnnals of surgical oncology2026

Single-Incision Plus One Robot-Assisted Abdominoperineal Resection Using the Hugo RAS System Through a Planned Stoma Site: A Novel Reduced-Port Robotic Surgery.

Shotaro Matsuda, Yoshiro Itatani, Masahiro Maeda, Takehito Yamamoto, Ryosuke Okamura, Yu Yoshida, Koya Hida, Kazutaka Obama

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shotaro MatsudaDepartment of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Yoshiro ItataniDepartment of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan. itatani@kuhp.kyoto-u.ac.jp.
Masahiro MaedaDepartment of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Takehito YamamotoDepartment of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Ryosuke OkamuraDepartment of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Yu YoshidaDepartment of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Koya HidaDepartment of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Kazutaka ObamaDepartment of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundReduced-port surgery has been developed to minimize abdominal wall trauma while maintaining the benefits of minimally invasive surgery. However, reduced-port robotic rectal surgery remains technically challenging due to interference of external arms. The modular design of the Hugo RAS system (Medtronic, Minneapolis, MN, USA) provides greater flexibility in arm positioning to minimize external arm interference without compromising instrument maneuverability

methodsIn abdominoperineal resection (APR), the incision for a permanent colostomy is inevitable. We report the first case of completely robot-assisted APR performed using the Hugo RAS system through a planned stoma site. Three robotic trocars were inserted through the planned left lower-quadrant stoma site, and one arm through the right lower quadrant. We call this approach SIPORS, Single-Incision Plus One Robot-assisted Surgery. The procedure is presented in the accompanying video.

resultsAs the first case, a 50-year-old woman with rectal cancer underwent APR after systemic chemotherapy. The console time was 167 min. The procedure was completed without significant robotic arm interference. The postoperative course was uneventful except for transient cystitis. The circumferential and distal resection margins were 3 and 35 mm, respectively. The mesorectal specimen was complete, 25 lymph nodes were harvested, and the pathological stage was pT3N2bM1.

conclusionsSIPORS using the Hugo RAS at a planned stoma site was technically feasible and achieved an oncologically acceptable resection in this patient. It may offer improved cosmesis, reduced postoperative pain, fewer wound complications, and a lower risk of trocar-site incisional hernia. Further experience is needed to confirm its reproducibility and clinical benefits.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.